FDA Approves Use Of Fluarix Under An IND; GSK To Submit BLA In First Half ’05
GlaxoSmithKline plans to establish a presence in the U.S. influenza vaccine market with a BLA submission for Fluarix in the first half of 2005
GlaxoSmithKline plans to establish a presence in the U.S. influenza vaccine market with a BLA submission for Fluarix in the first half of 2005